Larry Blandford, EVP, Managing Partner for Precision, moderates a video panel discussion tackling the evergreen challenge of how to demonstrate the short- and long-term value of a therapy when clinical data are lacking. The panel includes a variety of stakeholder perspectives, from payers to IDNs to economists. Jeremy Schafer, Senior Vice President and Head of the Access Experience Team, will share his thoughts, leveraging his payer experience at one of the top 5 largest PBMs. Avi Mamidi, Senior Director, former Formulary Manager and P&T Co-Chair at Sutter Health, will share thoughts from his work as a leader at a large IDN, and will discuss the impact on HCPs and patients. Rebecca Dean, Associate Director on the HEOR team, and David Carr, Senior Engagement Manager on the Global Pricing and Market Access Team will share their thoughts from a research and economist perspective from US and UK, respectively.
To view this free on-demand webinar, please click here.